BioWorld - Tuesday, March 31, 2026

BioWorld Science

Sep. 14, 2021

View Archived Issues

Pre-existing chromosomal instability may predict response to paclitaxel

Read More

ORAI1 behind the pathogenesis of pulmonary arterial hypertension

Read More

C-118P demonstrates antiproliferative activity in models of HCC

Read More

ARN-75039 or ARN-75041 as potent arenavirus fusion inhibitors

Read More

ASCT2 is a prognostic marker in renal cell carcinoma

Read More

Twist Bioscience and Adicet collaborate on discovery of gamma delta T-cell cancer therapies

Read More

OncoPLEX yields promising results in animal models of GBM

Read More

Repurposing ritonavir as potential disease-modifying therapy for dystonia

Read More

USAMRIID to test Navrogen's small-molecule NK cell activators against SARS-CoV-2 infection

Read More

Discovery of apigenin derivative with potential to overcome drug-resistant MET-mutant RCC

Read More

PearlRiverBio patents EGFR and HER2 mutant inhibitors

Read More

Tempest Therapeutics licenses intellectual property to cancer target from University of California

Read More

Beta Pharma presents new GTPase KRAS mutant inhibitors

Read More

vTv Therapeutics discloses glucokinase activators

Read More

SQZ announces celiac disease as first autoimmune clinical translation of TAC platform

Read More

Strong nectin-4 expression tied to poor prognosis in UTUC

Read More

Satellos reports preclinical data on drug candidate in mouse model of DMD

Read More

Kinnate presents preclinical data on next-generation pan-FGFR inhibitor KIN-3248

Read More